ARKK vs VNDA
ARK Innovation ETF (ARKK) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
ARKK does not have a complete income-statement cache yet.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
ARKK currently screens at market cap $0. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the ARKK and VNDA stock pages for the full models.
Not investment advice.